Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Aug 1;285(Pt 3):827–831. doi: 10.1042/bj2850827

Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme.

M Hubbes 1, R M D'Agrosa 1, J W Callahan 1
PMCID: PMC1132870  PMID: 1497620

Abstract

GM1 ganglioside beta-galactosidase (beta-Gal) is deficient in the autosomal recessive disorder GM1 gangliosidosis. A portion of the enzyme occurs in a complex with neuraminidase and an additional glycoprotein, protective protein, but the nature of the interactions conferring the stability of the complex is unknown. Affinity chromatography of beta-Gal on p-aminophenylthiogalactose-Sepharose (PATG-Sepharose) at pH 4.3, the pH optimum of beta-Gal, resulted in a 260-fold enrichment of beta-Gal, but the major protein in the fraction had an M(r) value of 74,000. Affinity chromatography on PATG-Sepharose at pH 5.2 showed substantial enrichment (4000-fold) of beta-Gal, and the mature form of the enzyme (M(r) 64,000) was the major protein in the preparation. Using h.p.l.c. molecular-sieve chromatography, we found that about 15% of the total beta-Gal occurred in a high-M(r) form (greater than 600,000), the presumptive complex, with 85% eluting at M(r) 150,000, suggestive of a dimer. This distribution was independent of both high (60 mg/ml) and low (5 mg/ml) protein concentration and the pH (pH 4.3 or 5.2) of the sample applied to the column. Furthermore, incubation for 90 min at 37 degrees C, conditions which had previously been suggested as optimal for formation of the complex, had no effect on this distribution. Further fractionation by anion-exchange chromatography and a second affinity column step yielded a beta-Gal preparation that contained a single polypeptide chain (M(r) 64,000), was devoid of neuraminidase and protective protein (absent carboxypeptidase activity), and when injected into rabbits gave rise to monospecific rabbit antisera. We conclude that the protein composition of the complex is variable (i.e. it is different when isolated at pH 4.3 and 5.2) and that the amount of beta-Gal tightly associated with the complex constitutes a small fraction of the total beta-Gal activity. The more prevalent form of the enzyme is a beta-Gal homodimer that is stable and devoid of either neuraminidase activity or protective protein.

Full text

PDF
827

Images in this article

829Fig. 1.
on p.829
830Fig. 3.
on p.830

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpers D. H. Separation and isolation of rat and human intestinal beta-galactosidases. J Biol Chem. 1969 Mar 10;244(5):1238–1246. [PubMed] [Google Scholar]
  2. Asp N. G. Human small-intestinal -galactosidases. Separation and characterization of three forms of an acid -galactosidase. Biochem J. 1971 Jan;121(2):299–308. doi: 10.1042/bj1210299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheetham P. S., Dance N. E. The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver. Biochem J. 1976 Jul 1;157(1):189–195. doi: 10.1042/bj1570189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. D'Agrosa R. M., Callahan J. W. In vitro activation of neuraminidase in the beta-galactosidase-neuraminidase-protective protein complex by cathepsin C. Biochem Biophys Res Commun. 1988 Dec 15;157(2):770–775. doi: 10.1016/s0006-291x(88)80316-4. [DOI] [PubMed] [Google Scholar]
  5. D'Agrosa R. M., Hubbes M., Zhang S., Shankaran R., Callahan J. W. Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts. Biochem J. 1992 Aug 1;285(Pt 3):833–838. doi: 10.1042/bj2850833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. D'Azzo A., Hoogeveen A., Reuser A. J., Robinson D., Galjaard H. Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4535–4539. doi: 10.1073/pnas.79.15.4535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frost R. G., Holmes E. W., Norden A. G., O'Brien J. S. Characterization of purified human liver acid beta-D-galactosidases A2 and A3. Biochem J. 1978 Oct 1;175(1):181–188. doi: 10.1042/bj1750181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Galjart N. J., Gillemans N., Harris A., van der Horst G. T., Verheijen F. W., Galjaard H., d'Azzo A. Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases. Cell. 1988 Sep 9;54(6):755–764. doi: 10.1016/s0092-8674(88)90999-3. [DOI] [PubMed] [Google Scholar]
  9. Galjart N. J., Gillemans N., Meijer D., d'Azzo A. Mouse "protective protein". cDNA cloning, sequence comparison, and expression. J Biol Chem. 1990 Mar 15;265(8):4678–4684. [PubMed] [Google Scholar]
  10. Gatt S. Enzymatic hydrolysis of sphingolipids. V. Hydrolysis of monosialoganglioside and hexosylceramides by rat brain beta-galactosidase. Biochim Biophys Acta. 1967 Feb 14;137(1):192–195. doi: 10.1016/0005-2760(67)90027-6. [DOI] [PubMed] [Google Scholar]
  11. Jones C. S., Mahuran D., Lowden J. A., Callahan J. W. Human placental beta-galactosidase: structural and immunological observations. Can J Biochem Cell Biol. 1984 Jun;62(6):529–534. doi: 10.1139/o84-070. [DOI] [PubMed] [Google Scholar]
  12. Kress B. C., Miller A. L. Characterization of the acid beta-D-galactosidases from human urine. Clin Chim Acta. 1978 Apr 3;85(1):23–32. doi: 10.1016/0009-8981(78)90096-7. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Lo J., Mukerji K., Awasthi Y. C., Hanada E., Suzuki K., Srivastava S. K. Purification and properties of sphingolipid beta-galactosidases from human placenta. J Biol Chem. 1979 Jul 25;254(14):6710–6715. [PubMed] [Google Scholar]
  16. Lodish H. F. Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion. J Biol Chem. 1988 Feb 15;263(5):2107–2110. [PubMed] [Google Scholar]
  17. Mahuran D. J., Neote K., Klavins M. H., Leung A., Gravel R. A. Proteolytic processing of pro-alpha and pro-beta precursors from human beta-hexosaminidase. Generation of the mature alpha and beta a beta b subunits. J Biol Chem. 1988 Apr 5;263(10):4612–4618. [PubMed] [Google Scholar]
  18. Mahuran D., Lowden J. A. The subunit and polypeptide structure of hexosaminidases from human placenta. Can J Biochem. 1980 Apr;58(4):287–294. doi: 10.1139/o80-038. [DOI] [PubMed] [Google Scholar]
  19. Norden A. G., Tennant L. L., O'Brien J. S. GM1 ganglioside beta-galactosidase. A. Purification and studies of the enzyme from human liver. J Biol Chem. 1974 Dec 25;249(24):7969–7976. [PubMed] [Google Scholar]
  20. O'Brien J. S., Warner T. G. Sialidosis: delineation of subtypes by neuraminidase assay. Clin Genet. 1980 Jan;17(1):35–38. doi: 10.1111/j.1399-0004.1980.tb00111.x. [DOI] [PubMed] [Google Scholar]
  21. Okada S., O'Brien J. S. Generalized gangliosidosis: beta-galactosidase deficiency. Science. 1968 May 31;160(3831):1002–1004. doi: 10.1126/science.160.3831.1002. [DOI] [PubMed] [Google Scholar]
  22. Oshima A., Tsuji A., Nagao Y., Sakuraba H., Suzuki Y. Cloning, sequencing, and expression of cDNA for human beta-galactosidase. Biochem Biophys Res Commun. 1988 Nov 30;157(1):238–244. doi: 10.1016/s0006-291x(88)80038-x. [DOI] [PubMed] [Google Scholar]
  23. Takeda E., Kuroda Y., Toshima K., Naito E., Ito M., Miyao M., Kominami E., Katunuma N. Involvement of thiol proteases in galactosialidosis. Clin Chim Acta. 1986 Mar 16;155(2):109–115. doi: 10.1016/0009-8981(86)90271-8. [DOI] [PubMed] [Google Scholar]
  24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Van Diggelen O. P., Schram A. W., Sinnott M. L., Smith P. J., Robinson D., Galjaard H. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency. Biochem J. 1981 Oct 15;200(1):143–151. doi: 10.1042/bj2000143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Verheijen F. W., Palmeri S., Galjaard H. Purification and partial characterization of lysosomal neuraminidase from human placenta. Eur J Biochem. 1987 Jan 2;162(1):63–67. doi: 10.1111/j.1432-1033.1987.tb10542.x. [DOI] [PubMed] [Google Scholar]
  27. Verheijen F. W., Palmeri S., Hoogeveen A. T., Galjaard H. Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein. Eur J Biochem. 1985 Jun 3;149(2):315–321. doi: 10.1111/j.1432-1033.1985.tb08928.x. [DOI] [PubMed] [Google Scholar]
  28. Verheijen F., Brossmer R., Galjaard H. Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex. Biochem Biophys Res Commun. 1982 Sep 30;108(2):868–875. doi: 10.1016/0006-291x(82)90911-1. [DOI] [PubMed] [Google Scholar]
  29. van Diggelen O. P., Hoogeveen A. T., Smith P. J., Reuser A. J., Galjaard H. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency. Biochim Biophys Acta. 1982 Apr 21;703(1):69–76. doi: 10.1016/0167-4838(82)90012-7. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES